REFRACTORY THYROID GLAND CARCINOMA
Clinical trials for REFRACTORY THYROID GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY THYROID GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for REFRACTORY THYROID GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets genetic flaw in Kids' Tough-to-Treat cancers
Disease control OngoingThis study is testing an oral medication called tipifarnib in children and young adults (ages 1-21) whose advanced solid tumors, lymphoma, or histiocytic disorders have a specific genetic change in a gene called HRAS. The goal is to see if the drug can shrink tumors and control t…
Matched conditions: REFRACTORY THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
New drug cocktail aims to tame tough thyroid cancer
Disease control OngoingThis study is testing whether a combination of targeted drugs, with or without an immunotherapy drug, can help control advanced thyroid cancer that has spread and no longer responds to standard radioactive iodine treatment. It is for patients whose cancer has a specific genetic c…
Matched conditions: REFRACTORY THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Apr 04, 2026 05:05 UTC
-
New drug combo aims to Re-Sensitize tough thyroid cancers to standard treatment
Disease control OngoingThis study is testing if adding an oral drug called trametinib can make radioactive iodine treatment work again for people with advanced thyroid cancer that has spread or come back and no longer responds to iodine. The goal is to see if trametinib helps the cancer absorb more iod…
Matched conditions: REFRACTORY THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug combo aims to tame tough thyroid cancers
Disease control OngoingThis study is testing whether a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—can help control advanced thyroid cancer that has stopped responding to radioactive iodine and has worsened after one prior targeted therapy. The goal is to see if this three-drug a…
Matched conditions: REFRACTORY THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC